Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
|
KMS MEDISURGI LIMITED (C1N- U51397MH1999PLC119118) Our Company was originally incorporated as 'KMS Medisurgi Private Limited' In Mumbai. Maharashtra under the provisions ot the Companies Act, 1956 vide Certificate of incorporation dated 25th March. 1999 bearing Registration Number 119118 issued by the Registrar of Companies. Mumbai. Maharashtra. Our Company was converted in to a Public United Company and consequently the name was changed to 'KMS Medisurgi United' vide fresh Certificate of Incorporation dated 15th June. 2016 issued by the Registrar of Companies, Mumbai. Maharashtra. The Corporate Identification Number of our Company is U51397MH1999PLC119118. For further details of Incorporation, change of name and registered office of our Company, please refer to chapter titled 'General Information' and 'Our History and Corporate Structure' beginning on page 38 and 109 respectively of the Prospectus. Registered Office: 297/301 May Building. Ground Floor.
Marine Lines (East). Princess Street. Mumbai - 400 002. Maharashtra. India PROMOTERS OF OUR COMPANY: MS. MONI DIAMONDS LIMITED, MR. GAURANG PRATAPRAI KANAKIA & MR, ANAND PRATAPRAI KANAKIA BASIS OF ALLOTMENT PUBLIC ISSUE OF 9,00,000 EQUITY SHARES OF RS. 10 EACH ('EQUITY SHARES') OF KMS MEDISURGI LIMITED ('KMS' OR THE 'COMPANY' OR THE 'ISSUER') FOR CASH AT A PRICE OF RS. 30 PER SHARE (THE 'ISSUE PRICE'), AGGREGATING TO RS. 270.00 LACS ('THE ISSUE'), OF WHICH, 52,000 EQUITY SHARES OF RS. 10 EACH WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKERS TO THE ISSUE (THE 'MARKET MAKER RESERVATION PORTION'). THE ISSUE LESS THE MARKET MAKER RESERVATION PORTION i.e. ISSUE OF 8.48,000 EQUITY SHARES OF RS. 10 EACH IS HEREINAFTER REFERRED TO AS THE 'NETISSUE'. THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 27.27% AND 25.70%. RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF THE COMPANY. In terms of Prospectus dated 30th March. 2017 and as per Regulation 43 (4) of SEBl
(ICDR) Regulations. 2009 wherein a minimum of 50 % of the Net Issue to Public shall be
made available to shall be initially made available to Retail Individual Investors as the
case may be. The balance net offer of shares to the public shall be made available for
allotment to a) Individual applicants other than retail investors and b) other investors
including corporate bodies / institutions inrespective of no. of shares applied for The
unsubscribed portion of the net offer to any one of the categories specified in (a) or (b)
Shall/may be made available for allocation in any other category, if so required. THE FACE VALUE OF THE EQUITY SHARES IS RS. 10/- EACH AND THE
ISSUE PRICE IS RS 30/- EACH. THE ISSUE PRICE IS 3.00 TIMES OF THE FACE VALUE. The Equity Shares offered through the Prospectus are proposed to be listed on the SME platform of BSE Limited ('BSE') in terms of the chapter XB of the SEBl (ICDR) Regulations. 2009 as amended from time to time. Company has received an approval letter dated 16th November, 2016 from BSE for using its name in the offer document for listing of our Shares on the SME platform of BSE. The designated stock exchange is BSE Limited. All Applicants are mandatorily to participate in the Issue through APPLICATION SUPPORTED BY BLOCKED AMOUNT ('ASBA') process by providing the details of the respective bank accounts in which the corresponding application amounts were blocked by Self Certified Syndicate Banks (the 'SCSBs'). SUBSCRIPTION DETAILS The Issue has received 315 applications for 19.00.000 Equity Shares (Including Market Maker Application of 52.000 Equity Shares) resulting 2.111 times subscription. One (1) application of 4,000 Equity Shares was not banked, hence 314 applications for 18.96.000 Equity Shares (Including Market Maker Application of 52,000 Equity Shares) resulting 2.107 times subscription was considered. The details of the applications received in the Issue (before technical rejections) are as follows; Detail of the Applications Received (Before Technical Rejection & withdrawal of application):
The details of applications rejected by the Registrar on technical grounds (including withdrawals) are detailed below:
Details of the Valid Applications Received (After Technical Rejection & withdrawal):
ALLOCATION: The Basis of Allotment was finalized in consultation with the Designated Stock Exchange - BSE Limited on 20th April. 2017. A. Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to the Market Maker, at the Issue price of Rs. 30/- per Equity Share, was finalised in consultation with BSE. The category was subscribed by 1.000 time. The total number of shares allotted in this category is 52.000 Equity shares in full out of reserved portion of 52.000 Equity Shares. B. Allocation to Retail Individual Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Retail Individual Investors, at the Issue price of Rs. 30/- per Equity Share, was finalized in consultation with BSE. The category was subscribed by 2.642 times. Total number of shares allotted in this category is 5.28,000 Equity Shares. The category wise basis of allotment is as under:
C. Allocation to Non Retail Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Non Retail Investors, at the Issue price of Rs. 30 - per Equity Share, was finalized in consultation with BSE. The category was subscribed by 1.613 times. Total number of shares allotted in this category is 3,20.000 Equity Shares. The category wise basis of allotment is as under:
The Board of Directors of the Company at its meeting held on 20th
April. 2017 has taken on record the Basis of Allocation of Equity Shares approved by the
Designated Stock Exchange viz. BSE and has authorized the corporate action for the
transfer of the Equity Shares/dispatch of share certificates to various successful
applicants. The allotment advice and/or rejection letters are being dispatched to the
address of the Applicants as registered with the depositories / as filled in the
application form on or before 24th April. 2017. Further, the instructions to Self
Certified Syndicate Banks being processed on or prior to 24th April. 2017. In case the
same is not received within 10 days, investors may contact at the address given below. The
Equity Shares allocated to successful applicants are being credited to then beneficiary
accounts subject to validation of the account details with the depositories concerned. The
Company is taking steps to get the Equity Shares admitted for trading on the SME Platform
of BSE Limited within Six working days from the date of the closure of the Issue The
trading is proposed to be commenced on or before 25th April, 2017 subject to receipt of
listing and trading approvals from BSE Limited. The details of the allotment made would also be hosted on the website of the Registrar
to the Issue. Karvy Computershare Private Limited at All future correspondence in this
regard may kindly be addressed to the Registrar to the Issue quoting fun name of the
First/ Sote applicants, serial number of the Application Form, number of shares applied
for and ASBA Bank details at the address of the Registrar given below:
|
The KMS Medisurgi IPO basis of allotment (published above) tells you how shares are allocated to you in KMS Medisurgi IPO and category wise demand of IPO share.
Visit the KMS Medisurgi IPO allotment status page to check the number of shares allocated to your application.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
